Heng Hsin Tang

Health Technology

Consumer Services

Profile

Heng Hsin Tang served as a Non-Executive Director at TBG Diagnostics Ltd.
from 2014 to 2015 and as the Managing Director at PharmaSynth Pty Ltd.
in 2014-2015.
Mr. Tang received an undergraduate degree and an MBA from The University of Queensland.

Former positions of Heng Hsin Tang

Companies	Position	End
TBG DIAGNOSTICS LIMITED	Chief Executive Officer	2014-07-27
PharmaSynth Pty Ltd. PharmaSynth Pty Ltd. Pharmaceuticals: MajorHealth Technology PharmaSynth Pty Ltd. develops drugs and provides contract manufacturing services. The firm’s services include biopharmaceutical contract manufacturing, GMP manufacture of recombinant proteins and vaccines, microbial products, small molecule synthesis for human and veterinary use, synthetic organic chemistry, production of GMP material for pre-clinical studies and clinical trial material batches for Phase 1, 2 and 3 clinical studies. The company was founded in 2009 and is headquartered in Darra, Australia.	Chief Executive Officer	2015-03-15

See the detail of Heng Hsin Tang's experience

Training of Heng Hsin Tang

The University of Queensland

Masters Business Admin

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Heng Hsin Tang's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	2
TBG Diagnostics Ltd. TBG Diagnostics Ltd. Pharmaceuticals: MajorHealth Technology TBG Diagnostics Ltd. engages in the research, development, and manufacture of biopharmaceuticals. It operates through the InVitro Diagnostics segment, which involves in the research of biological drugs and the retail and wholesale of veterinary drugs. The company was founded on September 26, 1989 and is headquartered in Melbourne, Australia.	Health Technology
PharmaSynth Pty Ltd. PharmaSynth Pty Ltd. Pharmaceuticals: MajorHealth Technology PharmaSynth Pty Ltd. develops drugs and provides contract manufacturing services. The firm’s services include biopharmaceutical contract manufacturing, GMP manufacture of recombinant proteins and vaccines, microbial products, small molecule synthesis for human and veterinary use, synthetic organic chemistry, production of GMP material for pre-clinical studies and clinical trial material batches for Phase 1, 2 and 3 clinical studies. The company was founded in 2009 and is headquartered in Darra, Australia.	Health Technology